CLINICAL_TRIALS
trial_result
· 2022-11-08
Clinical Trial Update: Early Administration of Prothrombin Concentrate Complex in Patients With Acute Hemorrhage Following Severe Trauma [Phase 3]
Summary
Phase 3 trial evaluating early administration of Prothrombin Concentrate Complex in patients with acute hemorrhage after severe trauma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University Hospital, Grenoble | Conditions: Shock, Hemorrhagic | Phase 3 | Status: COMPLETED